GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » Other Income (Expense)

ImmunoPrecise Antibodies (ImmunoPrecise Antibodies) Other Income (Expense) : $-0.00 Mil (TTM As of Jan. 2024)


View and export this data going back to 2011. Start your Free Trial

What is ImmunoPrecise Antibodies Other Income (Expense)?

ImmunoPrecise Antibodies's other income expense for the ImmunoPrecise Antibodies's pretax income for the three months ended in Jan. 2024 was $-0.09 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.00 Mil.

ImmunoPrecise Antibodies Other Income (Expense) Historical Data

The historical data trend for ImmunoPrecise Antibodies's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Other Income (Expense) Chart

ImmunoPrecise Antibodies Annual Data
Trend Dec13 Dec14 Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 -0.06 -0.99 0.50 0.17

ImmunoPrecise Antibodies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.01 -0.05 0.15 -0.09

ImmunoPrecise Antibodies Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImmunoPrecise Antibodies  (NAS:IPA) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

ImmunoPrecise Antibodies (ImmunoPrecise Antibodies) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » Other Income (Expense)
Comparable Companies
VYNE AURX QSAM UNCY TARA HRGN ICU FBIO BCLI NKGN OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
TQB:Germany
Address
3204 - 4464 Markham Street, Victoria, BC, CAN, V8Z 7X8
Website
https://www.immunoprecise.com
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.